Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
48.00
-0.10 (-0.21%)
Apr 3, 2025, 4:08 PM HKT

Keymed Biosciences Statistics

Total Valuation

HKG:2162 has a market cap or net worth of HKD 13.23 billion. The enterprise value is 11.74 billion.

Market Cap 13.23B
Enterprise Value 11.74B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

HKG:2162 has 275.60 million shares outstanding. The number of shares has increased by 0.22% in one year.

Current Share Class n/a
Shares Outstanding 275.60M
Shares Change (YoY) +0.22%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) n/a
Owned by Institutions (%) 25.19%
Float 184.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 27.60
PB Ratio 4.78
P/TBV Ratio 5.04
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -21.41
EV / Sales 25.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.30.

Current Ratio 3.30
Quick Ratio 2.97
Debt / Equity 0.30
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -33.92

Financial Efficiency

Return on equity (ROE) is -18.85% and return on invested capital (ROIC) is -11.69%.

Return on Equity (ROE) -18.85%
Return on Assets (ROA) -10.23%
Return on Invested Capital (ROIC) -11.69%
Return on Capital Employed (ROCE) -20.74%
Revenue Per Employee 362,160
Profits Per Employee -435,855
Employee Count 1,258
Asset Turnover 0.11
Inventory Turnover 0.14

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +52.62% in the last 52 weeks. The beta is 0.00, so HKG:2162's price volatility has been lower than the market average.

Beta (5Y) 0.00
52-Week Price Change +52.62%
50-Day Moving Average 36.00
200-Day Moving Average 36.06
Relative Strength Index (RSI) 78.84
Average Volume (20 Days) 2,534,124

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2162 had revenue of HKD 455.60 million and -548.31 million in losses. Loss per share was -2.09.

Revenue 455.60M
Gross Profit 442.61M
Operating Income -666.26M
Pretax Income -541.29M
Net Income -548.31M
EBITDA -611.32M
EBIT -666.26M
Loss Per Share -2.09
Full Income Statement

Balance Sheet

The company has 2.29 billion in cash and 801.58 million in debt, giving a net cash position of 1.49 billion or 5.41 per share.

Cash & Cash Equivalents 2.29B
Total Debt 801.58M
Net Cash 1.49B
Net Cash Per Share 5.41
Equity (Book Value) 2.63B
Book Value Per Share 10.04
Working Capital 1.83B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 97.15%, with operating and profit margins of -146.24% and -120.35%.

Gross Margin 97.15%
Operating Margin -146.24%
Pretax Margin -118.81%
Profit Margin -120.35%
EBITDA Margin -134.18%
EBIT Margin -146.24%
FCF Margin n/a

Dividends & Yields

HKG:2162 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.22%
Shareholder Yield -0.22%
Earnings Yield -4.14%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a